Clinical Trials Sponsored by Diabetes Schwerpunktpraxis

Total 3961 results

Diabetes Schwerpunktpraxis
Woerwag Pharma GmbH & Co. KG

Unknown

Effects of Benfotiamine on Intraepidermal Nerve Fiber Density (IENFD)

Diabetic Neuropathies

Germany
Sante Diabete Mali
Bridges program, International Diabetes Federation

Completed

A Randomized Trial of an Intensive Education Intervention Using a Network of Involved Diabetic Patients (Peer Educators) to Improve Glycemic Control of Type 2 Diabetic Patients

Diabetes

Mali
Joslin Diabetes Center
American Diabetes Association

Completed

Metabolic Effects of Betaine Supplementation

Obesity | Dysglycemia

United States
Medtronic Diabetes
Juvenile Diabetes Research Foundation

Completed

Effect of Closed Loop Glucose Control on Exercise-Associated Hypoglycemia (ePID-03)

Type 1 Diabetes Mellitus

United States
Medtronic Diabetes

Recruiting

Multi-center Trial in Adult and Pediatric Patients With Type 1 Diabetes Using Hybrid Closed Loop System and Control at Home

Type 1 Diabetes

United States, Spain, New Zealand, Canada, France, Germany, Italy, Sweden, United Kingdom
Medtronic Diabetes

Completed

Safety Evaluation of the Advanced Hybrid Closed Loop (AHCL) System

Type 1 Diabetes Mellitus

United States
Medtronic Diabetes

Completed

ADvanced Hybrid Closed Loop Study in Adult Population With Type 1 Diabetes (ADAPT)

Type 1 Diabetes

France, United Kingdom, Germany
DreaMed Diabetes

Completed

DreaMed Advisor Pro System in Subjects With Type 1 Diabetes Treated With MDI Therapy

Diabetes Mellitus, Type 1 | Insulin-dependent Diabetes Mellitus

Israel
Medtronic Diabetes

Completed

A Pivotal Study to Evaluate Guardian™ Connect CGM System Performance in China

Diabetes Mellitus

China
Medtronic Diabetes

Completed

A Pivotal Study to Evaluate Enlite™ Sensor Performance With iPro™2 in China

Diabetes Mellitus

China
Medtronic Diabetes

Terminated

Qingdao: Insulin Pump Follow-Up Program

Type 1 Diabetes

China
Medtronic Diabetes

Completed

CareLink Connect - Technical Evaluation Study

Diabetes Mellitus

Denmark, Netherlands
Medtronic Diabetes

Completed

A Performance Evaluation of the Enlite Glucose Sensor to Support a Full 144 Hours(6Days) of Use

Type 2 Diabetes Mellitus | Type 1 Diabetes Mellitus

United States
Medtronic Diabetes

Completed

OpT2mise Glucose Control in Type 2 Diabetes Mellitus (DM) With Insulin Pump Therapy (OpT2mise)

Diabetes Mellitus, Type 2

United States, France, Germany, Austria, Canada, Hungary, Israel, Italy, Macedonia, The Former Yugoslav Republic of, Netherlands, Serbia, South Africa, Spain
Medtronic Diabetes

Completed

User Evaluation of the MiniMed 640G Insulin Pump

Type 1 Diabetes | Type 2 Diabetes

United Kingdom, Australia
Medtronic Diabetes

Completed

Outpatient Study to Evaluate Safety and Effectiveness of the Low Glucose Suspend Feature (ASPIRE)

Type 1 Diabetes

United States
Medtronic Diabetes

Completed

An Inpatient Evaluation of Six-Day Subcutaneous Glucose Sensor Performance (6-DayFU)

Diabetes

United States
Medtronic Diabetes

Completed

Feasibility Study for Training Pump Naïve Subjects To Use The Paradigm® System And Evaluate Effectiveness (STAR2)

Type 1 Diabetes

United States
Medtronic Diabetes

Completed

Effectiveness Study of the Guardian RT in Type 1 Diabetics

Type 1 Diabetes Mellitus

Slovenia, United Kingdom, France, Germany, Israel, Italy, Sweden
Medtronic Diabetes

Recruiting

In-Home Study With MiniMed™ 780G Pump Automated Control in Type 2-Evaluation of the AHCL System in Adults With Insulin-requiring Type 2 Diabetes

Type 2 Diabetes Treated With Insulin

United States
Medtronic Diabetes

Completed

Use of the Guardian™ Connect System With Smart Connected Devices

Type 1 Diabetes Mellitus

United States
Medtronic Diabetes

Completed

Evaluation of Updated Continuous Glucose Monitoring (CGM) Form Factor in Adults, Adolescents and Pediatrics

Type 2 Diabetes Mellitus | Type 1 Diabetes Mellitus

United States, China
Medtronic Diabetes

Completed

Feasibility Studies of Personalized Closed Loop

Type 1 Diabetes

United States
Medtronic Diabetes

Completed

Safety Evaluation of the Hybrid Closed Loop (HCL) System in Pediatric Subjects With Type 1 Diabetes

Type 1 Diabetes

United States, Israel
Medtronic Diabetes

Completed

Evaluation of Extended Wear Infusion Set (EWIS) in Patients With Type 1 Diabetes

Diabetes

United States
Medtronic Diabetes

Withdrawn

A Performance Evaluation of the Harmony 1 Sensors in Adults and Pediatrics

Type 1 Diabetes | Type 2 Diabetes
Medtronic Diabetes

Completed

Feasibility Study of New Subcutaneous Glucose Sensor With Recording Devices

Type 1 Diabetes | Type 2 Diabetes

United States
Medtronic Diabetes

Completed

SWITCH - Sensing With Insulin Pump Therapy to Control HbA1c (SWITCH)

Diabetes Mellitus, Type 1

Netherlands, Slovenia, Denmark, Austria, Italy, Luxembourg, Spain
Medtronic Diabetes

Completed

Hybrid Closed Loop Pivotal Trial in Type 1 Diabetes

Type 1 Diabetes

United States, Israel
Medtronic Diabetes

Completed

Post Approval Study of the TS Feature With the 530G Pump System Supplemented With Commercial Patient Data

Diabetes

United States
Medtronic Diabetes

Completed

Routine Use of Sensor-Augmented Pump Therapy - a Follow up Study

Diabetes

Sweden
Medtronic Diabetes

Completed

Obtain a Good Blood Glucose Control With the Paradigm Real Time System (RTD)

Type 1 Diabetes

France
Medtronic Diabetes

Completed

Study to Compare Efficacy of the MiniMed Paradigm REAL-Time System Vs. MDI in Subjects Naive to Insulin Pump Therapy (STAR3)

Type 1 Diabetes

United States, Canada
Medtronic Diabetes

Completed

An Inpatient Performance Evaluation of a New Subcutaneous Glucose Sensor

Type 2 Diabetes Mellitus | Type 1 Diabetes Mellitus

United States
Medtronic Diabetes

Withdrawn

A Feasibility Study to Evaluate the Performance of the Harmony 1 Sensors in Adults and Pediatrics

Type 1 Diabetes
Medtronic Diabetes

Completed

In Clinic Evaluation of the PLGM Feature (PLGM)

Type 1 Diabetes

United States
Medtronic Diabetes

Completed

Sensor Augmented Pump Therapy Versus Multiple Daily Injection Therapy

Type 2 Diabetes

China
Medtronic Diabetes

Completed

Use of the Paradigm 722 System to Improve Glycemic Control in Adult and Adolescent Subjects With Type 1 Diabetes (STAR1)

Type 1 Diabetes

United States
Medtronic Diabetes

Completed

Assess the Efficacy of the Low Glucose Suspend (LGS) Feature in the MiniMed Paradigm® X54 System

Type 1 Diabetes Mellitus

United States
Medtronic Diabetes

Withdrawn

A Performance Evaluation of the Enlite 3 Sensor

Type 1 Diabetes

United States
Joslin Diabetes Center
Abbott Diabetes Care

Completed

Blood/Interstitial Glucose Measurements and Cognitive Function During Hypoglycemia and Recovery

Hypoglycemia

United States
Joslin Diabetes Center
American Diabetes Association

Completed

Identifying and Overcoming Barriers to Diabetes Management in the Elderly: A Cost-effective Intervention Study (DISCO)

Diabetes

United States
Joslin Diabetes Center
American Diabetes Association

Completed

Using Conversation Maps to Reinforce Self-Care

Type 2 Diabetes

United States
Steno Diabetes Center Copenhagen
Juvenile Diabetes Research Foundation; Oeresund Diabetes Academy

Completed

Anti-Interleukin-1 in Diabetes Action (AIDA)

Type 1 Diabetes

Spain, Denmark, Netherlands, Germany, Italy, Poland, Switzerland
Medtronic Diabetes

Active, not recruiting

Evaluation of the MiniMed™ 780G System in Type 1 Adult and Pediatric Subjects Utilizing Insulin Fiasp®

Type 1 Diabetes

United States, Canada, Australia
Medtronic Diabetes

Active, not recruiting

Evaluation of the MiniMed 780 System in Paediatric Subjects (LENNY)

Diabetes type1 | Children, Only

Italy, United Kingdom, Finland, Slovenia
Medtronic Diabetes

Completed

Safety and Effectiveness of the MiniMed™ 780G System With DS5 CGM

Type 1 Diabetes

United States
Medtronic Diabetes

Completed

InPen User Experience

Diabetes Type 1

Sweden
Medtronic Diabetes

Completed

Evaluation of Meal Gesture Dosing in Adults With Type 1 Diabetes

Type 1 Diabetes

Israel
Medtronic Diabetes

Completed

Impact of Acetaminophen on Performance of Guardian™ Sensor (3) in Adults

Type 2 Diabetes Mellitus | Type 1 Diabetes Mellitus

United States

Clinical Trials Sponsored by Diabetes Schwerpunktpraxis

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Saint Lucia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations